Boston Scientific Corporation (BSX)
-NYSE 9.10 
0.06(0.66%) May 17, 4:00PM EDT|After Hours
:
9.29 0.19 (2.09%) May 17, 7:59PM EDT
| Prev Close: | 9.04 |
|---|
| Open: | 8.98 |
|---|
| Bid: | 9.10 x 400 |
|---|
| Ask: | 9.47 x 1000 |
|---|
| 1y Target Est: | 8.37 |
|---|
| Beta: | 1.24 |
|---|
| Next Earnings Date: | 24-Jul-13 |
|---|
| Day's Range: | 8.97 - 9.14 |
|---|
| 52wk Range: | 4.79 - 9.18 |
|---|
| Volume: | 23,520,986 |
|---|
| Avg Vol (3m): | 18,583,900 |
|---|
| Market Cap: | 12.29B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -3.28 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Risky Stocks In An Expensive Marketat Seeking Alpha(Sun 9:57AM EDT)
- Cramer's Top Stock Picks: BSX BAX FBat TheStreet(Sat, May 18)
- Cramer's 'Mad Money' Recap: Next Week's Game Planat TheStreet(Fri, May 17)
- Jim Cramer's Down and Out Turnaround Playat CNBC(Fri, May 17)
- [video] Bargain in a Roaring Marketat CNBC(Fri, May 17)
- Why This Big Buyback Isn't a Long-Term Solutionat Motley Fool(Fri, May 17)
- Alleged Patent Infringement by BSXZacks(Fri, May 17)
- Boston Scientific Presents Clinical Data at Digestive Disease Week®PR Newswire(Fri, May 17)
- Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013PR Newswire(Fri, May 17)
- Vascular Solutions Files Patent Infringement Complaint Against Boston ScientificGlobeNewswire(Thu, May 16)
- Analysts: Discover’s Network Business Is Undervalued and 3 More Research Notes to Look Intoat Wall St. Cheat Sheet(Thu, May 16)
- House's 37th vote on Obamacare comes amid broad gains for sectorat MarketWatch(Thu, May 16)
- Johnson & Johnson: At The Crossroads - Part IIIat Seeking Alpha(Thu, May 16)
- 4 Healthcare Stock Stories Prescribed for Investorsat Wall St. Cheat Sheet(Wed, May 15)
- Today's 3 Best Stocksat Motley Fool(Wed, May 15)
Key Statistics
| Forward P/E (1 yr): | 19.36 |
|---|
| P/S (ttm): | 1.71 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.41 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.10 |
|---|
| Mean Recommendation*: | 2.5 |
|---|
| PEG Ratio (5 yr expected): | 2.29 |
|---|
Business Summary
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. The company offers interventional cardiology products, including coronary stent systems used in the tre...
View More